Intralesional Rituximab for the Treatment of Conjunctival Indolent Lymphoma
Clinical trial NCT01514344 · COMPLETED
Trial details
- NCT number
- NCT01514344
- Sponsor
- Andres J. M. Ferreri
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.